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Abstract
Background
As antiretroviral therapy efficacy improves, HIV is gradually being recognized more as a
chronic disease within the aging HIV-infected population. While these individuals are surviv-
ing into old age, they may, however, be experiencing “accelerated aging” with greater
declines in physical function than that observed among comparably matched individuals
free of HIV. This decline is not well understood and it remains unclear if physical decline cor-
relates with the degree of immunosuppression based on CD4 lymphocyte nadir.
Methods
In a cross-sectional study of accelerated aging in the older HIV-infected population on anti-
retroviral therapy (ART), physical performance evaluations were completed on a cohort of
107 HIV-infected subjects, age 50 years or older (with no HIV-1 RNA >200 copies/mL in the
prior 12 months), and compared to reference ranges for age- and gender-matched HIV-
uninfected persons. Physical performance testing consisted of four validated assessments:
the 2.4-meter walk, 30-second chair stand, grip strength and 6-minute walk test.
Results
When compared to age- and gender-matched HIV-uninfected reference controls, older HIV-
infected persons had diminished physical function. No correlation was found between physi-
cal function and degree of immunosuppression as determined by pre-ART CD4 nadir.
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Conclusions
Despite improved survival, HIV–infected adults on suppressive ART have diminished physi-
cal function compared to HIV-uninfected persons. The degree of HIV-associated immuno-
suppression does not correlate with the observed degree of physical function decline in
older HIV-infected persons, suggesting the decline is mediated by other mechanisms.
Introduction
Between 2007 and 2009, the prevalence of HIV-infected adults aged 50 years and older
increased from 28.6% to 32.7% [1]. By the end of 2015, it has been estimated that greater than
50% of HIV-infected adults in the U.S. were age 50 years and older [2]. With long-term sur-
vival of HIV-infected persons now a reality, there is growing concern among patients and pro-
viders alike that older HIV-infected persons are experiencing ‘accelerated’ aging, including
more rapid decline in physical function. Biological mechanisms for this apparent decline are
poorly elucidated but are thought to include higher rates of co-morbidities and smoking, pro-
longed antiretroviral therapy (ART) [3], chronic HIV infection with concomitant inflamma-
tion and underlying immunosuppression [4], and/or low bone and muscle mass [5].
Prior studies of physical function among HIV-infected persons have mostly used partici-
pant self-report and have primarily included mostly younger male participants (averaging 50
years of age) [6–8]. In addition, previous studies describing functional decline have included
participants with chronic pain, wasting syndrome, co-morbid conditions and/or symptomatic
HIV infection–all of which can act as confounding variables to negatively impact physical
capabilities [9–12]. For example, a cross-sectional analysis of self-reported data from the Veter-
ans Aging Cohort Study was able to show that there was no significant difference in physical
function between the average HIV-infected and HIV-uninfected 50-year-old. In addition, this
study concluded that the presence of a co-morbid condition (chronic pulmonary disease)
resulted in significant functional decline in HIV-infected adults relative to HIV-uninfected
adults [6]. A cross-sectional analysis of physical function based on responses to a questionnaire
demonstrated that higher CD4 counts and undetectable HIV-1 viral loads were associated
with better physical function [13]. Finally, HIV-infected men in the Multicenter AIDS Cohort
Study were found to have a greater-than-expected decline in accelerated longitudinal gait
speed over time [14]. These aforementioned studies suggest diminished physical function in
aging HIV-infected persons, but illustrate the lack of real-time, direct objective measurements
of function in healthy older HIV-infected persons (both male and female) who have controlled
HIV replication on ART.
To better assess physical function in older persons with HIV infection, we evaluated physi-
cal function using validated physical performance tests in older HIV-infected individuals on
effective ART and compared these to published reference ranges for healthy controls of similar
age and gender. We hypothesized that a history of significant immunosuppression (as assessed
by CD4 nadir) would negatively impact current physical function.
Methods
Participants
HIV-infected subjects were recruited from the Duke University HIV Clinic in Durham, North
Carolina, during 2013–2014. Eligibility criteria included: (a) age 50 years old or older at time
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of enrollment; and, (b) on suppressive ART for the past year (no HIV-1 RNA >200 copies/mL
in the prior 12 months). Exclusion criteria included the presence of conditions that would pre-
vent the subject from safely undergoing functional testing, such as: (a) active unstable angina,
(b) recent (<6 months) history of myocardial infarction, (c) history of ventricular tachycardia,
(d) uncontrolled hypertension (diastolic BP >120 mm/Hg), (e) recent (<6 months) history of
stroke or any residual neurological deficits affecting physical function, (f) active substance
abuse affecting participation in study, (g) dementia or diagnosis of mental or behavioral disor-
ders that preclude study participation, (h) severe hearing or vision loss, and (i) chronic pain
that may limit performance testing. Subjects completed a one-time visit to capture the follow-
ing: demographics, body mass index (BMI), estimated duration of HIV infection, prior/cur-
rent ART history, HIV-associated opportunistic infections, co-morbidities, lifestyle habits
including tobacco and alcohol use, nadir/current CD4 counts, and initial HIV-1 RNA. All
physical performance tests were performed during this same visit.
The protocol was approved by the Duke University Institutional Review Board (IRB#
Pro00032905), and all participants gave written informed consent.
Physical performance testing
Participants underwent physical performance testing using four validated functional assess-
ments: the 2.4-meter walk, 30-second chair stand, grip strength, and 6-minute walk test. All
tests were performed by trained study staff according to standardized protocols.
The 2.4-meter walk test is designed to measure gait speed (measured in meters per second),
walked on a measured course at usual and maximal walking speed. Participants were given
several meters to accelerate and decelerate before and after the test distance. This test is an
effective indicator of functional status and is predictive of future institutionalization and sur-
vival/mortality [15]. The 30-second chair stand, which assesses lower extremity strength,
requires subjects to stand all the way up and down from a chair as many times as possible in 30
seconds. This test can discriminate between fallers and non-fallers [16]. Grip strength was
measured via a Jamar dynamometer, an instrument that tests hand function and/or strength.
Subjects squeeze the dynamometer which then records the intensity of grip strength. The grip
strength test has been found in other studies to be predictive of mortality [17]. Aerobic endur-
ance is measured by the 6-minute walk test. Subjects walk as fast as possible down a hallway
and around a cone and back for 6 minutes. The 6-minute walk test is a good indicator of aero-
bic capacity [18].
Reference controls
Physical performance test results for this study were compared to well-established reference
ranges for healthy controls of similar age and gender from the literature [15–21]. Additionally,
differences for gait speed and the 6-minute walk test were calculated between our observed val-
ues and the age- and gender-matched reference ranges and were compared to clinically signifi-
cant meaningful differences published in the literature (available for gait speed, 30-second
chair stand, and 6-minute walk test) [22–23].
Comorbidity index
A co-morbidity index (ranging from 0–5) was created by summing the number of co-morbidi-
ties each participant reported, including cardiovascular, pulmonary, renal, liver, and malig-
nancy. Each participant was thus assigned an index score, which was subsequently used in
statistical analysis.
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Statistical analysis
Statistical analyses were performed using SAS software, version 9.4 (SAS Institute, Cary NC)
[24]. Demographic statistics are displayed by frequency and percentages for binary and ordinal
variables, and by means and standard deviations for continuous variables. For predictor group
comparisons, by, for example, CD4 nadir groups, the mean of the results of each physical per-
formance test was calculated and shown. To control for non-normal distributions in the out-
comes, differences between groups were tested using a 2-sample Wilcoxon or Kruskal-Wallis
tests. Pearson correlations were used to test the impact of various antiretrovirals (ARVs) on
physical function, partialling for 11 pre-selected confounding variables (BMI, gender, race,
age, estimated duration of HIV, CD4 nadir, current CD4 count, tobacco use, alcohol use, illicit
drug use, and co-morbidity index).
Results
A total of 107 older HIV-infected persons on suppressive ART (HIV-1 RNA <200 copies/mL
in the prior 12 months) were enrolled. Of these, 75 (70%) were male (Table 1) with a mean age
of 60.3 years (range 50.2–78.1 years) and mean BMI of 28.6 kg/m2 (range 17.4–51.2 kg/m2).
Most participants were Black/African American (n = 64; 60%) or white, non-Hispanic (n = 40;
37%). The mean duration of known HIV infection was 15.3 years (range 1.4–31.7 years), and
the most common current ART regimen was efavirenz/emtricitabine/tenofovir disoproxil
fumarate (n = 30, 28%).
At enrollment, the mean CD4 count of the cohort was 691 cells/mm3 (range 83–2,096 cells/
mm3). The majority of subjects (n = 73; 68%) had previously had a nadir CD4 count<200
cells/mm3, and 42/107 (39%) had had a CD4 nadir <50 cells/mm3. Demographic and clinical
characteristics were similar between the low and higher CD4 nadir groups (Table 1) with a
trend towards significance for race by CD4 nadir. A total of 58 (54%) of the cohort had experi-
enced HIV-associated opportunistic infections, most commonly Pneumocystis pneumonia
(n = 23; 21%) and esophageal candidiasis (n = 36; 34%).
Overall, the sample had a modest number of co-morbidities with the mean co-morbidity
index being 1.44. The most common co-morbidities were cardiovascular disease (61 partici-
pants [57%]), liver disease (39 participants [36%]), renal disease (18 participants [17%]),
Table 1. Overall demographics and clinical characteristics.
Total (n = 107) CD4 nadir <200 cells/mm3 (n = 73) CD4 nadir >350 cells/mm3 (n = 34)
Age 50–59 years old 52 (49%) 37 (51%) 15 (44%)
60–69 years old 49 (46%) 31 (42%) 18 (53%)
70 years old 6 (6%) 5 (7%) 1 (3%)
Gender Male 75 (70%) 50 (68%) 25 (74%)
Female 32 (30%) 23 (32%) 9 (26%)
Race/Ethnicity Black/African American 64 (60%) 48 (66%) 16 (46%)
White/Caucasian 40 (37%) 23 (31%) 17 (50%)
Hispanic 3 (3%) 2 (3%) 1 (3%)
BMI < 25 kg/m2 28 (26%) 21 (29%) 7 (21%)
25–29.9 kg/m2 42 (39%) 30 (41%) 12 (35%)
> 30 kg/m2 37 (35%) 22 (30%) 15 (44%)
BMI = Body mass index.
https://doi.org/10.1371/journal.pone.0179874.t001
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pulmonary disease (18 participants [17%]), and malignancy (17 participants [16%]). Of the 73
participants (68%) who were current or former smokers, the mean cumulative smoking his-
tory was 25.6 pack-years.
There was no significant effect on physical function from any particular type of antiretrovi-
ral therapy, including the use of drugs with greater potential for mitochondrial toxicity (didan-
osine, stavudine, and zidovudine) [25], even after controlling for a range of variables
(including BMI, gender, race, age, estimated duration of HIV, CD4 nadir, current CD4 count,
tobacco use, alcohol use, illicit drug use, and the co-morbidity index).
Individually, some of the demographic variables were related to physical function
(Table 2). Most notably, males performed significantly better on grip strength and gait speed
(measured by 2.4-meter walk at both usual and maximal speed). Participants with lower BMIs
performed better on the 2.4-meter walk at both usual and maximal speed. Compared to
blacks, white participants performed better on the 2.4-meter walk at both usual and maximal
speed. Increasing age and higher co-morbidity indices both correlated with worse perfor-
mance on the 6-minute walk test. Participants who were not current smokers had significantly
better performance on the 30-second chair stand and the 6-minute walk test. Alcohol and
illicit drug use, HIV duration, CD4 nadir, and current CD4 count did not significantly affect
physical function. Additional analyses were performed to control for type-1 error in which
age, gender and the co-morbidity index were found to be the most related to the outcomes of
interest. While there was indication that other variables were related (such as white race and
HIV duration), the multivariate P value, when controlling for other predictors, was not
significant.
Table 2. Correlation between clinical characteristics and physical function.
Gait speed–
usual (m/s)
Gait speed–
max (m/s)
30-second
chair stand
Grip
strength
(kg)
6– minute
walk test (m)
Multivariate p value,
individual predictor
Multivariate p value,
controlled for all other
predictors
Age -0.16 -0.17 0.011 -0.16 -0.28** 0.0099 0.0500
Male gender 0.23* 0.25** 0.17 0.65*** 0.18 <.0001 <.0001
White race 0.25** 0.33*** 0.18 0.12 0.17 0.0272 0.1505
BMI -0.22* -0.25** -0.15 -0.078 -0.14 0.1717 0.3150
Current
tobacco use
-0.16 -0.11 -0.24* -0.046 -0.22* 0.1493 0.2306
Co-morbidity
index
-0.14 -0.094 -0.12 0.086 -0.43*** <.0001 0.0004
Current
alcohol use
0.16 0.15 0.11 0.13 0.15 0.6282 0.9986
Current illicit
drug use
0.0047 0.017 0.0014 0.074 -0.15 0.2555 0.4621
HIV duration 0.011 0.15 -0.11 -0.053 -0.10 0.0188 0.3215
CD4 nadir 0.060 -0.039 -0.024 -0.021 -0.023 0.8095 0.6749
Current CD4
count
0.064 0.043 -0.0079 -0.050 0.063 0.8978 0.8462
All values listed are Pearson Correlation Coefficients. N = 107. Prob > [r] under H0.
*p<0.05;
**p<0.01;
***p<0.001
Gait speed was measured by the 2.4-meter walk test.
https://doi.org/10.1371/journal.pone.0179874.t002
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In our study, HIV-infected patients had diminished physical performance when compared
to gender- and age-matched reference standards obtained from the literature [15–21]
(Table 3). Additionally, there was a clinically significant, meaningful difference of>0.1 m/s for
gait speed and>50 m for the 6-minute walk test [22–23] (Table 4).
Impact of CD4 nadir on physical function
Physical function did not significantly differ between those with a CD4 nadir of<200 versus
>350 cells/mm3 (Table 3). There was also no significant difference in physical function
between those with a CD4 nadir of<50 versus >350 cells/mm3.
Table 3. Physical function compared to normal reference values ranges.
Gait Speed–
Usual
Speed (m/s)
Normal
Values
Usual
Speed (m/s)
Gait Speed–
Maximal
Speed (m/s)
Normal
Values
Maximal
Speed (m/s)
30-Second
Chair Stand
Normal
Values
Grip
Strength
(kg)
Normal
Values (kg)
6-Minute
Walk Test
Distance
(m)
Normal
Values (m)
Total
(n = 107)
1.17 1.76 12.72 33.45 432.99
Female
age 50–59
1.14 1.40 1.65 2.00 11.38 N/A 24.09 29.9–30.9 421.75 N/A
Female
age60
1.02 1.27–1.30 1.58 1.74–1.77 11.88 10–17 23.81 18.0–25.9 388 471–538
Male age
50–59
1.23 1.39 1.85 2.07 13.19 N/A 39.04 44.1–50.6 479.36 N/A
Male age
60
1.19 1.33–1.36 1.80 1.93–2.08 13.18 11–19 36.09 28.0–41.7 414.45 527–572
CD4 nadir
<200
cells/mm3
1.15 N/A 1.76 N/A 12.66 N/A 33.19 N/A 427.40 N/A
CD4 nadir
>350
cells/mm3
1.21 N/A 1.77 N/A 12.85 N/A 34.01 N/A 444.83 N/A
Values reported as means.
Gait speed was measured by the 2.4-meter walk test.
Normal values were obtained from the literature using established reference standards appropriate for age and gender-matched HIV-uninfected persons
[15–21].
https://doi.org/10.1371/journal.pone.0179874.t003
Table 4. Differences in physical function between HIV-infected study participants and normal reference ranges (controlled for age and gender).
n Difference from Norms Clinically Significant Meaningful Difference
Gait Speed–Usual Speed (m/s) 107 -0.19 ± 0.25 >0.1 m/s
Gait Speed–Maximal Speed (m/s) 107 -0.21 ± 0.37 >0.1 m/s
30-Second Chair Stand 55* -1.11 ± 4.06 2.0–2.6
Grip Strength (kg) 107 -3.68 ± 8.65 Not established
6-Minute Walk Test Distance (m) 106** -105.15 ± 100.85 >50 m
*For the 30-second chair stand, 52 participants were removed from the analysis as age/gender-matched references were unavailable for persons <age 60.
**One person did not perform the 6-Minute Walk Test.
Gait speed was measured by the 2.4-meter walk test.
Clinically significant meaningful differences were obtained from the literature [22–23].
https://doi.org/10.1371/journal.pone.0179874.t004
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Discussion
The number of HIV-infected older adults is increasing in clinics worldwide, and ensuring
optimal care for this population is an important priority. In this study, HIV-infected older per-
sons on virologically suppressive antiretroviral therapy demonstrated significantly diminished
physical function compared to similarly aged persons without HIV infection, putting them at
risk for falls and mobility-related disability [26–28].
Using established reference standards appropriate for age and gender-matched HIV-unin-
fected persons [15–21], physical function was diminished in all performance measures, most
notably in gait speed and the 6-minute walk test. These results may in fact predict these HIV-
infected persons will not be physically independent at age 90 [19]. For example, a 60-year-old
male should be able to do 17 chair stands in 30 seconds and walk 680 yards (622 m) in 6 min-
utes to be independent at age 90. In our cohort, males under the age of 60 were only able to do
an average of 13.19 chair stands in 30 seconds and walk 479.36 m in 6 minutes.
There was a clinically significant, meaningful difference of>0.1 m/s for gait speed and>50
m for the 6-minute walk test between our subjects and the reference standards [22–23]. Based
on our findings, the average walking speed for older HIV-infected subjects was slower than
what is needed to safely cross the street (1.2 m/s) [29]. The difference for the 6-minute walk
test was especially large at -105.15 m, more than two times the clinically significant meaningful
difference of 50 m.
Possible reasons for diminished physical function include HIV infection itself, ART-related
adverse events/toxicities, and/or the presence of significant co-morbidities. Although older
nucleoside reverse-transcriptase inhibitors (NRTIs) such as didanosine, stavudine, and zido-
vudine [25] have been shown to cause mitochondrial toxicity, a history of having taken these
medications did not significantly affect physical function in our cohort, even after controlling
for confounding variables. Individually, variables such as male gender, lower BMI, current
non-smoker status, white race, younger age, and lower co-morbidity index were associated
with better performance on certain physical function tests. Since BMI and smoking are modifi-
able factors, they are potential targets for future interventions.
It should be noted that physical function did not significantly differ between those with a
history of greater immunosuppression (CD4 nadir<50 or <200 cells/mm3) and those with
lesser immunosuppression (CD4 nadir >350 cells/mm3). The relatively small sample size pre-
cludes definitive conclusions, but these data suggest that while the observed decline in physical
function is clearly related to HIV infection, it is not mediated by the degree of prior immuno-
suppression experienced prior to initiation of ART.
This study has a few geographical and demographic limitations; our cohort was based in
the Southeast and predominantly black. While it is unclear if our results are specific to the
Southeast, this region carries a heavy burden of the U.S. HIV epidemic. Despite only compris-
ing a third of the overall U.S. population, the Southeast accounts for an estimated 44% of all
people living with HIV [30]. With regards to new infections, North Carolina is ranked in the
top 10 states, with Durham County ranking third of all 100 counties [31]. In addition, although
the U.S. Census Bureau projections for July 2015 noted that the population aged 50–69 is
approximately 80% white and 5% black, blacks represent 37.2% of Durham County’s HIV-pos-
itive population compared to 13% of the overall U.S. population [32]. Therefore, our cohort
was representative of the HIV-positive patient population in Durham County, North Carolina.
The magnitude of differences observed between our study participants and healthy refer-
ence controls appears to predict poorer health status, greater disability, increased medical-sur-
gical visits, longer hospital stays, and higher health care-associated costs in older HIV-infected
patients. This emphasizes the importance of finding appropriate intervention strategies and
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warrants additional research regarding mechanisms and predictors of decline. The implica-
tions of these data are significant for planning long-term HIV management approaches, par-
ticularly strategies for preserving physical function and quality of life in older HIV-infected
patient populations.
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